Erythropoietin ameliorate experimental allergic encephalomyelitis
10.3969/j.issn.1000-484X.2010.04.009
- VernacularTitle:促红细胞生成素改善实验性变态反应性脑脊髓炎症状观察
- Author:
Xiang ZHANG
;
Qinying LI
;
Baoguo XIAO
- Publication Type:Journal Article
- Keywords:
Erythropoietin;
Experimental allergic encephalomyelitis;
Neuroprotecion
- From:
Chinese Journal of Immunology
2010;26(4):325-329,334
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the beneficial effect of erythropoietin(EPO)on experimental allergic encephalomyelitis(EAE).Methods: The severity of EAE mice with or without EPO therapy were evaluated through clinical symptoms score and histological observation.Mononuclear cells from spleens,lymph nodes, brains and lumber spinal cords were applied to flow cytometry to detect ratios of CD4~+T subgroup, scales of apoptotic and dead cells, levels of inflammatory cytokines.LDH release of peripheral mononuclear cells were examined after incubating with EPO at different concentrations.Results: EPO ameliorated clinical symptoms and infiltration of pathological inflammatory cells in EAE mice(P＜0.05); Ratio of CD4~+T subgroup, levels of IL-17 and IFN-γ in EAE mice with EPO therapy were significantly lower than those of EAE control group(P＜0.05).No statistical significant differences existed on scales of dead cells, levels of IL-10 and CD4~+ CD25~+ T cells (P＞0.05).EPO at the concentrstions of 1-1 000 U/ml had no effect on LDH release of peripheral mononuclear cells(P＞0.05).Conclusion: EPO play the role of neuroprotecion in EAE mice by the way of decreasing infiltrating inflammatory cells and lowering the levels of IL-17 and IFN-γ.
